N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide

C76H76Cl2N12O17P2 — CID 140749566

IUPACN-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide
SMILESCOc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(NC(=O)c5ccccc5)ncnc43)C[C@@H]2OP(=O)(CC[C@H]2O[C@@H](n3cnc4cnc(NC(=O)C(C)C)nc43)C[C@@H]2OP(=O)(CC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)Oc2ccccc2Cl)Oc2ccccc2Cl)(c2ccccc2)c2ccc(OC)cc2)cc1
InChIInChI=1S/C76H76Cl2N12O17P2/c1-45(2)71(92)86-74-79-39-55-69(85-74)89(43-82-55)65-37-61(106-108(96,104-57-22-14-12-20-53(57)77)34-32-59-56(91)36-64(101-59)88-40-46(3)72(93)87-75(88)95)60(102-65)33-35-109(97,105-58-23-15-13-21-54(58)78)107-62-38-66(90-44-83-67-68(80-42-81-70(67)90)84-73(94)47-16-8-6-9-17-47)103-63(62)41-100-76(48-18-10-7-11-19-48,49-24-28-51(98-4)29-25-49)50-26-30-52(99-5)31-27-50/h6-31,39-40,42-45,56,59-66,91H,32-38,41H2,1-5H3,(H,87,93,95)(H,79,85,86,92)(H,80,81,84,94)/t56-,59+,60+,61-,62-,63+,64+,65+,66+,108?,109?/m0/s1
InChIKeyCTZLUTPAMILGOI-NFNYRRBFSA-N
MW1562.36 g/mol
LogP13.02
Rot. Bonds29

About N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide

N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide (PubChem CID 140749566) has the molecular formula C76H76Cl2N12O17P2 and a molecular weight of 1562.36 g/mol. Its IUPAC name is N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide.

Molecular Properties

Compound NameN-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide
PubChem CID140749566
Molecular FormulaC76H76Cl2N12O17P2
Molecular Weight1562.36 g/mol
Exact Mass1560.43
IUPAC NameN-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide
SMILESCOc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(NC(=O)c5ccccc5)ncnc43)C[C@@H]2OP(=O)(CC[C@H]2O[C@@H](n3cnc4cnc(NC(=O)C(C)C)nc43)C[C@@H]2OP(=O)(CC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)Oc2ccccc2Cl)Oc2ccccc2Cl)(c2ccccc2)c2ccc(OC)cc2)cc1
InChIInChI=1S/C76H76Cl2N12O17P2/c1-45(2)71(92)86-74-79-39-55-69(85-74)89(43-82-55)65-37-61(106-108(96,104-57-22-14-12-20-53(57)77)34-32-59-56(91)36-64(101-59)88-40-46(3)72(93)87-75(88)95)60(102-65)33-35-109(97,105-58-23-15-13-21-54(58)78)107-62-38-66(90-44-83-67-68(80-42-81-70(67)90)84-73(94)47-16-8-6-9-17-47)103-63(62)41-100-76(48-18-10-7-11-19-48,49-24-28-51(98-4)29-25-49)50-26-30-52(99-5)31-27-50/h6-31,39-40,42-45,56,59-66,91H,32-38,41H2,1-5H3,(H,87,93,95)(H,79,85,86,92)(H,80,81,84,94)/t56-,59+,60+,61-,62-,63+,64+,65+,66+,108?,109?/m0/s1
InChIKeyCTZLUTPAMILGOI-NFNYRRBFSA-N
XLogP13.02
TPSA346.93 Ų
H-Bond Donors4
H-Bond Acceptors26
Rotatable Bonds29
Heavy Atoms109
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001562.36
LogP ≤ 513.02
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide?
The IUPAC name of N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide (CID 140749566) is N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide.
What is the SMILES notation for N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide?
The canonical SMILES for N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide is COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(NC(=O)c5ccccc5)ncnc43)C[C@@H]2OP(=O)(CC[C@H]2O[C@@H](n3cnc4cnc(NC(=O)C(C)C)nc43)C[C@@H]2OP(=O)(CC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)Oc2ccccc2Cl)Oc2ccccc2Cl)(c2ccccc2)c2ccc(OC)cc2)cc1.
What is the InChIKey of N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide?
The InChIKey is CTZLUTPAMILGOI-NFNYRRBFSA-N. The full InChI is InChI=1S/C76H76Cl2N12O17P2/c1-45(2)71(92)86-74-79-39-55-69(85-74)89(43-82-55)65-37-61(106-108(96,104-57-22-14-12-20-53(57)77)34-32-59-56(91)36-64(101-59)88-40-46(3)72(93)87-75(88)95)60(102-65)33-35-109(97,105-58-23-15-13-21-54(58)78)107-62-38-66(90-44-83-67-68(80-42-81-70(67)90)84-73(94)47-16-8-6-9-17-47)103-63(62)41-100-76(48-18-10-7-11-19-48,49-24-28-51(98-4)29-25-49)50-26-30-52(99-5)31-27-50/h6-31,39-40,42-45,56,59-66,91H,32-38,41H2,1-5H3,(H,87,93,95)(H,79,85,86,92)(H,80,81,84,94)/t56-,59+,60+,61-,62-,63+,64+,65+,66+,108?,109?/m0/s1.
What are the key properties of N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide?
N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide has a molecular weight of 1562.36 g/mol, XLogP of 13.02, 29 rotatable bonds, 4 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-[(2-chlorophenoxy)-[2-[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethyl]phosphoryl]oxy-5-[2-(2-methylpropanoylamino)purin-9-yl]oxolan-2-yl]ethyl]phosphoryl]oxyoxolan-2-yl]purin-6-yl]benzamide is sourced from PubChem (CID 140749566), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).